TOP TIERMARKET NEWSWIRE
News & sentiment

PACIRA BIOSCIENCES I (PCRX) — News & AI sentiment

PACIRA BIOSCIENCES I (PCRX) news roundup. 34 stories aggregated over the last 30 days. Average 30-day sentiment is 57.9/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $289K — net selling of $289K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
34
avg sentiment 57.9/100
Insider net (90d)
$289K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

PCRX news in the last 24 hours, 7 days, 30 days and 90 days

How much PCRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPCRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days3457.9/100PCRX headlines →
Last 90 days5257.8/100PCRX headlines →

Latest stories on PCRX

Oct 13
Oct 12
Oct 12
Oct 11
Oct 9
Oct 9
Oct 9
Oct 9
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Jefferies downgrades Pacira Pharmaceuticals stock rating on Viatris deal
Investing.com Analyst Ratings34 · bearishanalyst
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Why Pacira BioSciences Skyrocketed Today
The Motley Fool85 · bullishm&a
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Open PCRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →